
NAD+ IV therapy has moved from biohacker forums to concierge clinic menus, and patients now arrive asking about it by name. The foundational science is genuinely interesting. The human clinical evidence is genuinely early. Both of those things are true at once, and the honest version of this topic sits in the space between the hype and the dismissal. Here is what we actually know.
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell in your body. It is central to how cells convert food into usable energy and to a set of repair and signaling processes that keep cells functioning. This part is not in dispute — it is textbook biochemistry.
NAD+ levels decline with age. That, too, is well established. The leap that requires scrutiny is the next one: that raising NAD+ through an IV infusion produces the energy, recovery, and longevity benefits people are hoping for.
Here is where honesty matters. The case for NAD+ rests heavily on laboratory and animal research, where boosting NAD+ has produced striking effects on cellular aging markers. Translating that to meaningful, measurable benefits in healthy humans is where the evidence thins out.
Researchers who study this openly acknowledge that we are still in the early stages of human trials, and that the longevity and anti-aging benefits of raising NAD+ have not been established in large human studies. That does not mean NAD+ does nothing. It means the strongest claims — reversing aging, dramatically extending healthspan — are not yet backed by the kind of evidence that would let a clinician promise them. Anyone who tells you otherwise is selling certainty that does not exist yet.
Plenty of people finish a NAD+ infusion and report more energy, better focus, or easier recovery. Several things can be true here:
We would rather you understand those overlapping explanations than pretend the drip is the whole story.
A NAD+ infusion is delivered slowly, and the rate matters. Infused too quickly, NAD+ commonly causes chest tightness, flushing, nausea, or a racing sensation. Slowing the drip resolves it. This is one reason NAD+ belongs in a clinical setting with supervision rather than a self-administered kit.
Sessions typically run from under an hour to a few hours depending on dose, and pricing in the wider market ranges widely, often from a couple hundred dollars to considerably more per session. Cost is a legitimate part of the decision, and it is fair to weigh it against evidence that is still maturing.
NAD+ therapy is most reasonably approached as part of a broader wellness strategy, not a standalone fix. People drawn to it are often looking for support with energy, recovery, or healthy aging, frequently alongside other efforts.
It makes less sense as a first move if the fundamentals are not addressed. If your fatigue is driven by a thyroid issue, low iron, disrupted sleep, or a hormone imbalance, an infusion is not the answer to that — testing is. This is exactly why we start with labs rather than a drip.
Our position is straightforward. We will not oversell NAD+, and we will not dismiss it either. Before recommending it, we look at what is actually driving how you feel through functional wellness labs, so an infusion is a considered choice rather than a hopeful guess. If NAD+ fits, we deliver it at a controlled rate with supervision. If something more fundamental is going on, we would rather find that first.
The underlying biology is real, and many people report feeling better afterward. What is not yet established in large human studies is that raising NAD+ by infusion delivers the anti-aging and longevity benefits often advertised. It is reasonable to try with realistic expectations; it is not reasonable to expect miracles.
Oral precursors like NMN and NR raise NAD+ through a different route and are being actively studied. Whether oral or IV is better is an open question. Neither has settled the larger evidence gap. If you prefer oral, that is a fair conversation to have with a provider.
Given in a clinical setting at an appropriate rate, NAD+ is generally well tolerated. The common side effects — flushing, chest tightness, nausea — are tied to infusing too fast and ease when the rate is slowed. Supervision matters, which is why we do not consider it a do-it-yourself therapy.
There is no established universal protocol, which itself tells you something about the state of the evidence. Frequency should be individualized and revisited based on whether you are actually getting a benefit you can notice, not a fixed schedule sold in a package.
If you are curious about NAD+ and want a provider who will tell you where the evidence genuinely stands — and check whether something more basic is driving how you feel first — call Alpine Health & Wellness in Kalispell, MT at 406-361-7421. We will start with what is actually going on, then decide whether a drip earns its place in your plan.
You can also read about our broader approach to IV therapy and NAD+ through the seasons.
This article is for general educational purposes and does not constitute medical advice, nor does it establish a provider-patient relationship. NAD+ IV therapy is not FDA-approved to treat, cure, or prevent any disease, and individual results are not guaranteed. Please consult a qualified healthcare provider about your individual circumstances before beginning any new therapy.